PLEASANTON, Calif., July 14,
2022 /PRNewswire/ -- Following a comprehensive search
process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the
hiring of Jim Wilbur, Ph.D., as
Chief Commercial Officer, effective July
27. In this role, Wilbur will be responsible for driving
commercial strategy and execution and leading the company's sales,
support and marketing functions.
A life sciences entrepreneur and seasoned global commercial
executive, Wilbur brings nearly 30 years of experience building
businesses, developing high-performance teams and scaling
commercial organizations to drive growth and customer success.
"Jim's deep experience driving commercial excellence and
execution at scale make him the ideal person to lead our global
commercial team in this next phase of growth," said Serge Saxonov,
Co-founder and CEO of 10x Genomics. "What stood out from all the
other great candidates is Jim's detailed understanding and passion
of the sales craft, his ability to operate strategically from first
principles and his technical depth as a top-notch scientist. It's
an incredibly rare combination. He is a great fit with the 10x
mission and culture, is rigorous about process and data and has
tremendous energy to get things done. We're thrilled to welcome him
to the team."
Wilbur joins 10x Genomics from Meso Scale Discovery (MSD), the
world's leading provider of highly sensitive multiplex
immunoassays. Widely recognized for its innovative and robust
technology, MSD develops, manufactures and markets instruments and
assays for research use in life sciences and biodefense.
As part of the original team that started the operations of MSD,
Wilbur initially led the development of the company's core
technology and products. When MSD launched its first products in
2001, Wilbur assumed leadership for the company's commercial
function, building the global team responsible for marketing,
selling and servicing the company's portfolio of instruments and
consumables. Since that time, Wilbur has scaled MSD's global
commercial organization to deliver sustained high growth and
cultivate deep partnerships with customers.
"It's an exciting time to join the 10x team, be part of the
company's mission and have the opportunity to make a difference in
a transformational way," said Wilbur. "10x has a great foundation
to build on, and I have strong confidence in the company's
long-term opportunity and ability to fulfill the tremendous promise
of single cell and spatial biology. I look forward to helping the
team drive a strong culture of commercial excellence, deliver
meaningful value for customers and accelerate growth and
impact."
Wilbur earned his bachelor's degree in chemistry and
intellectual history from the University of
California, San Diego, and holds his Ph.D. in chemistry from
Stanford University. Prior to MSD, he
completed an NIH Postdoctoral Fellowship at Harvard University.
About 10x Genomics
10x Genomics is a life science
technology company building products to interrogate, understand and
master biology to advance human health. Our integrated solutions
include instruments, consumables and software for analyzing
biological systems at a resolution and scale that matches the
complexity of biology. 10x Genomics products have been adopted by
researchers around the world including in all of the top 100 global
research institutions as ranked by Nature in 2020 based on
publications and all of the top 20 global pharmaceutical companies
by 2020 research and development spend and have been cited in over
3,800 research papers on discoveries ranging from oncology to
immunology and neuroscience. Our patent portfolio comprises more
than 1,500 issued patents and patent applications.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-names-jim-wilbur-as-chief-commercial-officer-301587075.html
SOURCE 10x Genomics, Inc.